Changhua Yu

632 total citations
23 papers, 493 citations indexed

About

Changhua Yu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Changhua Yu has authored 23 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Changhua Yu's work include Esophageal Cancer Research and Treatment (8 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Changhua Yu is often cited by papers focused on Esophageal Cancer Research and Treatment (8 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Changhua Yu collaborates with scholars based in China. Changhua Yu's co-authors include Weiguo Zhu, Xi‐Lei Zhou, Wenjie Xia, Feng Jiang, Weidong Ma, Qixing Mao, Gaochao Dong, Yu‐Suo Tong, Wei Zeng and Fu-Zhi Ji and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Changhua Yu

21 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changhua Yu China 11 257 155 140 122 118 23 493
Chuanliang Peng China 13 253 1.0× 78 0.5× 139 1.0× 138 1.1× 99 0.8× 41 487
Manlio Monti Italy 12 114 0.4× 102 0.7× 195 1.4× 172 1.4× 89 0.8× 46 462
Kei Mitsuhashi Japan 8 279 1.1× 90 0.6× 188 1.3× 62 0.5× 89 0.8× 19 436
J Whiting United Kingdom 9 99 0.4× 105 0.7× 163 1.2× 300 2.5× 284 2.4× 15 559
Ceen‐Ming Tang United Kingdom 6 160 0.6× 151 1.0× 91 0.7× 48 0.4× 74 0.6× 8 419
Lourdes Flores‐Luna Mexico 15 68 0.3× 72 0.5× 166 1.2× 97 0.8× 269 2.3× 36 516
Dae Ho Ahn South Korea 9 166 0.6× 102 0.7× 37 0.3× 62 0.5× 123 1.0× 17 335
Jinlu Tong China 10 172 0.7× 152 1.0× 139 1.0× 57 0.5× 64 0.5× 19 515
Masayoshi Hioki Japan 12 142 0.6× 24 0.2× 203 1.4× 110 0.9× 142 1.2× 46 553
Masami Ijiri Japan 7 237 0.9× 177 1.1× 98 0.7× 27 0.2× 57 0.5× 18 362

Countries citing papers authored by Changhua Yu

Since Specialization
Citations

This map shows the geographic impact of Changhua Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changhua Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changhua Yu more than expected).

Fields of papers citing papers by Changhua Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changhua Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changhua Yu. The network helps show where Changhua Yu may publish in the future.

Co-authorship network of co-authors of Changhua Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Changhua Yu. A scholar is included among the top collaborators of Changhua Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changhua Yu. Changhua Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lv, Jie, Chunyang Yu, Chunyang Yu, et al.. (2025). Immunological biomarkers and gene signatures predictive of radiotherapy resistance in non-small cell lung cancer. Frontiers in Immunology. 16. 1574113–1574113.
3.
Tong, Yu‐Suo, et al.. (2024). Anlotinib inhibits cervical cancer cell proliferation and invasion by suppressing cytokine secretion in activated cancer-associated fibroblasts. Frontiers in Oncology. 14. 1412660–1412660. 2 indexed citations
4.
Tong, Yu‐Suo, et al.. (2023). Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma. Frontiers in Oncology. 13. 1257266–1257266. 7 indexed citations
5.
Zhao, Weiqiang, Yisheng Li, Guangyi Jin, et al.. (2022). MAGEA1 and hTERT Peptide Treatment Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC Treated Acute Myeloid Leukemia. Journal of Cancer. 13(4). 1252–1260. 4 indexed citations
6.
Xu, Yingying, Xi‐Lei Zhou, Changhua Yu, et al.. (2021). Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy. Frontiers in Oncology. 11. 655071–655071. 9 indexed citations
7.
Zhang, Li, Guangyi Jin, Changhua Yu, et al.. (2021). Lenalidomide improves the antitumor activity of CAR-T cells directed toward the intracellular Wilms Tumor 1 antigen. Hematology. 26(1). 818–826. 14 indexed citations
8.
Jin, Guangyi, Wei Zeng, Changhua Yu, et al.. (2020). Conjugation of TLR7 Agonist Combined with Demethylation Treatment Improves Whole-Cell Tumor Vaccine Potency in Acute Myeloid Leukemia. International Journal of Medical Sciences. 17(15). 2346–2356. 7 indexed citations
9.
Tong, Yu‐Suo, Lili Yang, Changhua Yu, et al.. (2020). Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs. Molecular Therapy — Oncolytics. 18. 1–13. 73 indexed citations
10.
Hu, Ke, Xianhao Liu, Yi Li, et al.. (2020). Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p. Medical Science Monitor. 26. e922253–e922253. 70 indexed citations
11.
Wang, Rong, Mei Ji, Meiqi Shi, et al.. (2020). Camrelizumab in the treatment of patients with advanced lung cancer: A multicenter, prospective, cohort study.. Journal of Clinical Oncology. 38(15_suppl). e21650–e21650. 2 indexed citations
12.
Ma, Weidong, Qixing Mao, Wenjie Xia, et al.. (2019). Gut Microbiota Shapes the Efficiency of Cancer Therapy. Frontiers in Microbiology. 10. 1050–1050. 138 indexed citations
13.
Zhou, Xi‐Lei, et al.. (2018). Combination of long noncoding RNA <em>MALAT1</em> and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer. OncoTargets and Therapy. Volume 11. 2333–2344. 17 indexed citations
14.
Zhou, Xi‐Lei, Yongqiang Li, Weiguo Zhu, et al.. (2017). Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Scientific Reports. 7(1). 42581–42581. 43 indexed citations
15.
Pu, Juan, Shanshan Qin, Yan Zhang, et al.. (2013). A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery. Journal of Cancer Research and Clinical Oncology. 139(4). 703–708. 20 indexed citations
16.
17.
18.
Zhu, Weiguo, Guangzhou Tao, Tao Li, et al.. (2011). Effects of postoperative 3-dimensional conformal radiotherapy on lymph node positive patients after radical resection of esophageal carcinoma. Zhonghua fangshe yixue yu fanghu zazhi. 31(5). 571–574. 1 indexed citations
19.
Yu, Changhua, Ren Yu, Weiguo Zhu, Yaqi Song, & Tao Li. (2011). Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery. Journal of Cancer Research and Clinical Oncology. 138(2). 255–259. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuanliang Peng Breakdown of academic impact, for papers by Manlio Monti Breakdown of academic impact, for papers by Kei Mitsuhashi Breakdown of academic impact, for papers by J Whiting Breakdown of academic impact, for papers by Ceen‐Ming Tang Breakdown of academic impact, for papers by Lourdes Flores‐Luna Breakdown of academic impact, for papers by Dae Ho Ahn Breakdown of academic impact, for papers by Jinlu Tong Breakdown of academic impact, for papers by Masayoshi Hioki Breakdown of academic impact, for papers by Masami Ijiri
Rankless by CCL
2026